ToolGen Incorporated (KOSDAQ:199800)

South Korea · Delayed Price · Currency is KRW

49,200

+500 (1.03%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gene Editing Related Technology Business	890.96M	1.10B	743.46M	1.60B
Gene Editing Related Technology Business Growth	-19.25%	48.41%	-53.45%	-
Total	890.96M	1.10B	743.46M	1.60B
Total Growth	-19.25%	48.41%	-53.45%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
North America	561.79M	654.79M	394.31M	350.57M
North America Growth	-14.20%	66.06%	12.48%	-
Korea	111.00M	175.69M	289.80M	850.36M
Korea Growth	-36.82%	-39.37%	-65.92%	-
Europe	108.19M	154.20M	59.36M	36.48M
Europe Growth	-29.84%	159.80%	62.71%	-
Asia, Etc.	109.98M	118.72M	-	359.87M
Asia, Etc. Growth	-7.36%	-	-	-
Total	890.96M	1.10B	743.46M	1.60B
Total Growth	-19.25%	48.41%	-53.45%	-

Source: S&P Global Market Intelligence.